Individuals Discontinuing Slimming Injections Gain Back Weight at a Quadrupled Rate Compared to Those on Conventional Diets

Image of pharmaceutical syringe and weighing machine
Weight management often requires ongoing approaches.

Fresh analysis reveals that people who come off popular slimming jabs like Mounjaro or Wegovy tend to recover lost weight far faster than those who stop traditional lifestyle plans.

Published data in a prominent medical journal demonstrates that while obese individuals often shed a large proportion of their body weight while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month after stopping.

"People purchasing these medications should be informed of the potential of fast weight regain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.

That rate of recovery suggests a return to pre-treatment mass within about 18 months.

Weighing Treatments

The analysis, which reviewed dozens of studies involving thousands of patients, compared the effects of the injectable medications with other pills.

Researchers note that people who lose weight through diet and exercise usually have a less rapid creep back—perhaps 100 grams monthly—after stopping.

The Reason for the Rapid Regain

Experts propose the mechanism of the jabs is key to understanding the accelerated rebound.

GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.

"Artificially providing GLP-1 concentrations far above than the body's typical production may cause the system to produce less of its endogenous GLP-1, and could diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.

"Discontinuation of this hormone supplement means appetite is unsuppressed, making overeating much more probable."

A Lifelong Issue?

The NHS recommend the injections for people with obesity-related medical conditions, alongside recommended diet and exercise modifications.

Many experts contend that, due to the significant potential of relapse, the therapy is often ongoing.

This opinion is supported by pharmaceutical companies, who state that the results "emphasize the persistent character of excess weight," akin to managing diseases like high blood pressure.

User Testimonies

Users who have discontinued the jabs explain a sudden resurgence of cravings.

"It was like a trigger flipping and you become starving," described a patient.

This challenge is exacerbated if individuals have not established permanent lifestyle or habit changes during treatment.

Widespread Interest

Recent estimates suggest that millions of adults in the UK have used these injections in the last 12 months, with desire remaining high.

  • Adoption is higher among females compared to men.
  • The middle-aged age group shows the greatest usage rates.
  • Many obtain the medications through private prescriptions rather than public health services.

Finally, experts caution that while these medications are powerful agents for shedding pounds, they are not a magic fix and long-term success likely depends on ongoing behavioural support.

Taylor King
Taylor King

Elara Vance is a renewable energy consultant with over a decade of experience in grid modernization and sustainable infrastructure projects across Europe.